Typhim Vi
NDC 49281-790, SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN, injection, solution, from Sanofi Vaccines US Inc..
- Product NDC
- 49281-790
- Status
- Listed
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103936
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49281-790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN25 ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Inactivated Salmonella Typhi Vaccine [EPC]; Polysaccharides, Bacterial [CS]; Vaccines, Inactivated [CS]; Vaccines, Typhoid [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49281-790-20 | 49281079020 | 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-790-20) / 10 mL in 1 VIAL, MULTI-DOSE (49281-790-38) |
| 49281-790-51 | 49281079051 | 1 SYRINGE in 1 PACKAGE (49281-790-51) / .5 mL in 1 SYRINGE (49281-790-88) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 49281-790 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49281-790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49281-790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.